Immunoprecise Antibodies Stock Forecast - Daily Balance Of Power

IPA Stock  USD 0.41  0.03  7.89%   
Immunoprecise Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Immunoprecise Antibodies stock prices and determine the direction of Immunoprecise Antibodies's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Immunoprecise Antibodies' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Immunoprecise Antibodies' Receivables Turnover is projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 595.41, whereas Inventory Turnover is forecasted to decline to 5.54. . The current year's Common Stock Shares Outstanding is expected to grow to about 26.9 M, whereas Net Loss is projected to grow to (22.7 M).
On October 22, 2024 Immunoprecise Antibodies had Daily Balance Of Power of 0.3333. Balance of Power indicator (or BOP) measures the strength of Immunoprecise Antibodies market sensitivity to bulls and bears. It estimates the ability of Immunoprecise Antibodies buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Immunoprecise Antibodies Balance of Power indicator one can determine a trend of the price direction.
Check Immunoprecise Antibodies VolatilityBacktest Immunoprecise AntibodiesTrend Details  

Immunoprecise Antibodies Trading Date Momentum

On October 23 2024 Immunoprecise Antibodies was traded for  0.54  at the closing time. Highest Immunoprecise Antibodies's price during the trading hours was 0.55  and the lowest price during the day was  0.50 . The net volume was 578.1 K. The overall trading history on the 23rd of October contributed to the next trading period price jump. The trading delta at closing time to the next next day price was 5.88% . The trading delta at closing time to current price is 27.45% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Immunoprecise Antibodies to competition

Other Forecasting Options for Immunoprecise Antibodies

For every potential investor in Immunoprecise, whether a beginner or expert, Immunoprecise Antibodies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immunoprecise Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immunoprecise. Basic forecasting techniques help filter out the noise by identifying Immunoprecise Antibodies' price trends.

View Immunoprecise Antibodies Related Equities

 Risk & Return  Correlation

Immunoprecise Antibodies Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Immunoprecise Antibodies' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Immunoprecise Antibodies' current price.

Immunoprecise Antibodies Market Strength Events

Market strength indicators help investors to evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By undertsting and applying Immunoprecise Antibodies stock market strength indicators, traders can identify Immunoprecise Antibodies entry and exit signals to maximize returns.

Immunoprecise Antibodies Risk Indicators

The analysis of Immunoprecise Antibodies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Immunoprecise Antibodies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting immunoprecise stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Immunoprecise Antibodies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunoprecise Antibodies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunoprecise Antibodies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunoprecise Antibodies Stock:
Check out Historical Fundamental Analysis of Immunoprecise Antibodies to cross-verify your projections.
For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.76)
Revenue Per Share
0.921
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.13)
Return On Equity
(0.64)
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunoprecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.